Relationship between Age and the Ability to Break Scored Tablets

by Kim Notenboom, Kim Notenboom, Herman Vromans, Herman Vromans, Maarten Schipper, Hubert G.M. Leufkens, Hubert G.M. Leufkens, Marcel Louis Bouvy, Marcel Louis Bouvy
Published 2016-07-01

Getting the Right Evidence After Drug Approval

by Rick A. Vreman, Rick A. Vreman, Hubert G. M. Leufkens, Aaron S. Kesselheim
Published 2020-09-01

The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism.

by Arlene M Gallagher, Tim Williams, Hubert G M Leufkens, Frank de Vries
Published 2016-01-01

Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.

by Yaser T Bazargani, Anthonius de Boer, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse
Published 2014-01-01

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study

by Daniel N. A. Ankrah, Margaret Lartey, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens
Published 2017-10-01

The views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescription.

by Erna Beers, Toine C G Egberts, Hubert G M Leufkens, Paul A F Jansen
Published 2013-01-01

Correction: Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data

by Arlene M. Gallagher, Liam Smeeth, Suzie Seabroke, Hubert G. M. Leufkens, Tjeerd P. van Staa
Published 2013-01-01

Correction: Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data.

by Arlene M. Gallagher, Liam Smeeth, Suzie Seabroke, Hubert G. M. Leufkens, Tjeerd P. van Staa
Published 2013-01-01

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.

by Arlene M Gallagher, Liam Smeeth, Suzie Seabroke, Hubert G M Leufkens, Tjeerd P van Staa
Published 2011-01-01

Essential medicines are more available than other medicines around the globe.

by Yaser T Bazargani, Margaret Ewen, Anthonius de Boer, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse
Published 2014-01-01

Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis

by Rick A. Vreman, Thomas F. Broekhoff, Hubert G.M. Leufkens, Aukje K. Mantel-Teeuwisse, Wim G. Goettsch
Published 2020-11-01

Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.

by Yared Santa-Ana-Tellez, Aukje K Mantel-Teeuwisse, Anahi Dreser, Hubert G M Leufkens, Veronika J Wirtz
Published 2013-01-01

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences

by H. Hilda Ampadu, Jarno Hoekman, Daniel Arhinful, Marilyn Amoama-Dapaah, Hubert G. M. Leufkens, Alex N. O. Dodoo
Published 2018-11-01

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

by Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, Andre W. Broekmans, Hubert G.M. Leufkens, Olaf H. Klungel
Published 2018-12-01

Are Further Interventions Needed to Prevent and Manage Hospital-Acquired Hyponatraemia? A Nationwide Cross-sectional Survey of IV Fluid Prescribing Practices

by Per Sindahl, Christian Overgaard-Steensen, Helle Wallach-Kildemoes, Marie Louise De Bruin, Hubert G. M. Leufkens, Kaare Kemp, Helga Gardarsdottir
Published 2020-08-01

Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana

by Edmund T. Nartey, Raymond A. Tetteh, Barbara A. Yankey, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens, Alexander N. O. Dodoo, Margaret Lartey
Published 2019-07-01

Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health f...

by H. Hilda Ampadu, Kwaku Poku Asante, Samuel Bosomprah, Samantha Akakpo, Pierre Hugo, Helga Gardarsdottir, Hubert G. M. Leufkens, Dan Kajungu, Alexander N. O. Dodoo
Published 2019-02-01

Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials.

by Cornelis A van den Bogert, Patrick C Souverein, Cecile T M Brekelmans, Susan W J Janssen, Gerard H Koëter, Hubert G M Leufkens, Lex M Bouter
Published 2016-01-01

The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.

by Corinne Klop, Paco M J Welsing, Hubert G M Leufkens, Petra J M Elders, Jetty A Overbeek, Joop P van den Bergh, Johannes W J Bijlsma, Frank de Vries
Published 2015-01-01

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

by Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse
Published 2021-07-01